towermansion https://blog.hatena.ne.jp/towermansion/ 勉強用 https://towermansion.hatenablog.com/ lung cancer～NSCLC～StageIV～Driver+ Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial ARTICLES| VOLUME 401, ISSUE 10378, P733-746, MARCH 04, 2023 THE LANCET Summary <Background>Sotorasib is a specific, irreversible inhibitor of the GTPase protei… 190 <iframe src="https://hatenablog-parts.com/embed?url=https%3A%2F%2Ftowermansion.hatenablog.com%2Fentry%2F2024%2F02%2F23%2F233441" title="KRAS G12C+, Stage IV NSCLC～CodeBreak200 - 勉強用" class="embed-card embed-blogcard" scrolling="no" frameborder="0" style="display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;"></iframe> Hatena Blog https://hatena.blog 2024-02-23 23:34:41 rich https://towermansion.hatenablog.com/entry/2024/02/23/233441 1.0 100%